https://www.prnewswire.com/news-releases/research-reports-on-biotech-equities----mast-therapeutics-array-biopharma-galena-biopharma-and-clovis-oncology-599326391.html
/PRNewswire/ -- Growing concerns that a victory by Democratic nominee Hillary Clinton in the presidential election will result in tighter regulations on...
research reportsarray biopharmabiotechequitiesmast
https://www.biospace.com/aslan-pharma-acquires-full-global-commercial-rights-for-varlitinib-from-array-biopharma
The new licensing agreement replaces the prior licensing agreement signed in 2011 to develop and sublicense varlitinib, which did not grant commercial rights...
aslanpharmaacquiresfullglobal